Article Details
Retrieved on: 2018-05-02 22:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Cambridge, Massachusetts-based Casma Therapeutics Inc, a biotechnology company, has raised $58.5 million in Series A funding. The investor was <b>Third</b> <b>Rock Ventures</b>. Source: Press Release. Print Email. PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here